Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
My bio page
Edit user profile
Signature
Reset the password
Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
A peer-reviewed protocol journal. No publication fee; no access fee.
Search
Overview
Published
Edited
Reviewed
Following
Feedback
Q&A
Mohammad Taghi Joghataei
Department of Neuroscience Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Iran
2 protocols
Kazem Mousavizadeh
Department of Molecular Medicine, Faculty of Advanced Technologies, Iran University of Medical Sciences, 2012-0
1 protocol
Somaieh Kazemnejad
Tissue Engineering department, Avicenna Research Institute, Tehran, 2008-0
1 protocol
Masoud Mehrpour
Department of Neurology, Faculty of Medicine, Iran University of Medical Sciences, Tehran
1 protocol
View all coauthors >
Amir Hassan Zarnani
Professor and chair, mmunology, Tehran University of Medical Sciences, Iran, 2017-0;Reproductive Immunology Research Center, Avicenna Research Institute, Iran, 2004-2017
Research focus
-
Contributions
1
Author merit
Reviewer merit
Editor merit
Education
Ph.D., Tarbiat Modares University, Iran, 2003
Publications
https://scholar.google.com/citations?user=i5mNfCcAAAAJ&hl=en
1 Protocol published
Intra-arterial Drug Delivery to the Ischemic Brain in Rat Middle Cerebral Artery Occlusion Model
Authors:
Fereshteh Azedi
,
Masoud Mehrpour
,
Somaieh Kazemnejad
,
Kazem Mousavizadeh
,
Amir Hassan Zarnani
and
Mohammad Taghi Joghataei
,
date:
12/05/2019,
view:
1995,
Q&A:
0
Rat transient middle cerebral artery occlusion (tMCAO) model is one of the most commonly used animal models in ischemic stroke studies. In the model, increasing safety and efficacy of therapeutic agent administration, such as stem cells and drugs ...
More >
following
More protocols >
0 Protocol feedback
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.